Cytomegalovirus in pregnancy and the neonate

F1000Research

Volumn 6, Issue , 2017, Pages

  Emery, Vincent C ^a   Lazzarotto, Tiziana ^b  

^a UNIVERSITY OF SURREY   (United Kingdom)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Antiviral therapy; Cytomegalovirus; Pathogenesis; Pregnancy

Indexed keywords

CYTOMEGALOVIRUS VACCINE; HYPERIMMUNE GLOBULIN; MONOCYTE CHEMOTACTIC PROTEIN 1; PLACEBO; PROTEIN BCL XL; RECOMBINANT CYTOMEGALOVIRUS GLYCOPROTEIN B VACCINE; STAT3 PROTEIN; SURVIVIN; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; VALGANCICLOVIR; WNT5A PROTEIN;

AMNION FLUID ANALYSIS; ANTIVIRAL THERAPY; CLINICAL TRIAL (TOPIC); CONGENITAL INFECTION; CYTOMEGALOVIRUS INFECTION; EPIDEMIOLOGICAL DATA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INNATE IMMUNITY; MIXED INFECTION; NONHUMAN; PHASE 2 CLINICAL TRIAL (TOPIC); PLACENTA; PREGNANCY; PRENATAL SCREENING; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; TROPHOBLAST; VACCINATION; VIRUS LOAD; VIRUS TRANSMISSION;

EID: 85015181824     PISSN: 20461402     EISSN: 1759796X     Source Type: Journal    
DOI: 10.12688/f1000research.10276.1     Document Type: Review

References (71)

1. Manicklal S Emery VC Lazzarotto T: The "silent" global burden of congenital cytomegalovirus. Clin Microbiol Rev. 2013;26(1):86-102. 23297260 10.1128/CMR.00062-12 3553672
2. Renzette N Gibson L Bhattacharjee B: Rapid intrahost evolution of human cytomegalovirus is shaped by demography and positive selection. PLoS Genet. 2013;9(9):e1003735. 24086142 10.1371/journal.pgen.1003735 3784496 F1000 Recommendation
3. Sijmons S Thys K Mbong Ngwese M: High-throughput analysis of human cytomegalovirus genome diversity highlights the widespread occurrence of gene-disrupting mutations and pervasive recombination. J Virol. 2015;89(15):7673-7695, pii: JVI.00578-15. 25972543 10.1128/JVI.00578-15 4505652 F1000 Recommendation
4. Cannon MJ: Congenital cytomegalovirus (CMV) epidemiology and awareness. J Clin Virol. 2009;46(Suppl 4):S6-10. 19800841 10.1016/j.jcv.2009.09.002
5. Cannon MJ Schmid DS Hyde TB: Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev Med Virol. 2010;20(4):202-13. 20564615 10.1002/rmv.655
6. Kenneson A Cannon MJ: Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol. 2007;17(4):253-76. 17579921 10.1002/rmv.535
7. Marshall GS Stout GG: Cytomegalovirus seroprevalence among women of childbearing age during a 10-year period. Am J Perinatol. 2005;22(7):371-6. 16215924 10.1055/s-2005-872590
8. Lanzieri TM Dollard SC Bialek SR: Systematic review of the birth prevalence of congenital cytomegalovirus infection in developing countries. Int J Infect Dis. 2014;22:44-8. 24631522 10.1016/j.ijid.2013.12.010 4829484 F1000 Recommendation
9. Stagno S Pass RF Dworsky ME: Congenital cytomegalovirus infection: The relative importance of primary and recurrent maternal infection. N Engl J Med. 1982;306(16):945-9. 6278309 10.1056/NEJM198204223061601
10. Wang C Zhang X Bialek S: Attribution of congenital cytomegalovirus infection to primary versus non-primary maternal infection. Clin Infect Dis. 2011;52(2):e11-3. 21288834 10.1093/cid/ciq085
11. Ornoy A Diav-Citrin O: Fetal effects of primary and secondary cytomegalovirus infection in pregnancy. Reprod Toxicol. 2006;21(4):399-409. 16580941 10.1016/j.reprotox.2005.02.002
12. Gaytant MA Rours GI Steegers EA: Congenital cytomegalovirus infection after recurrent infection: case reports and review of the literature. Eur J Pediatr. 2003;162(4):248-53. 12647198
13. Zalel Y Gilboa Y Berkenshtat M: Secondary cytomegalovirus infection can cause severe fetal sequelae despite maternal preconceptional immunity. Ultrasound Obstet Gynecol. 2008;31(4):417-20. 18383476 10.1002/uog.5255
14. Mussi-Pinhata MM Yamamoto AY Moura Brito RM: Birth prevalence and natural history of congenital cytomegalovirus infection in a highly seroimmune population. Clin Infect Dis. 2009;49(4):522-8. 19583520 10.1086/600882 2778219
15. Yamamoto AY Mussi-Pinhata MM Isaac Mde L: Congenital cytomegalovirus infection as a cause of sensorineural hearing loss in a highly immune population. Pediatr Infect Dis J. 2011;30(12):1043-6. 21814153 10.1097/INF.0b013e31822db5e2 3222783
16. Dollard SC Grosse SD Ross DS: New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol. 2007;17(5):355-63. 17542052 10.1002/rmv.544
17. Grosse SD Ross DS Dollard SC: Congenital cytomegalovirus (CMV) infection as a cause of permanent bilateral hearing loss: a quantitative assessment. J Clin Virol. 2008;41(2):57-62. 17959414 10.1016/j.jcv.2007.09.004
18. Dahle AJ Fowler KB Wright JD: Longitudinal investigation of hearing disorders in children with congenital cytomegalovirus. J Am Acad Audiol. 2000;11(5):283-90. 10821506
19. Fowler KB Dahle AJ Boppana SB: Newborn hearing screening: will children with hearing loss caused by congenital cytomegalovirus infection be missed? J Pediatr. 1999;135(1):60-4. 10393605 10.1016/S0022-3476(99)70328-8
20. Rycel M Wujcicka W Zawilińska B: Mixed infections with distinct cytomegalovirus glycoprotein B genotypes in Polish pregnant women, fetuses, and newborns. Eur J Clin Microbiol Infect Dis. 2015;34(3):585-91. 25348608 10.1007/s10096-014-2266-9 4356880 F1000 Recommendation
21. Sylwester AW Mitchell BL Edgar JB: Broadly targeted human cytomegalovirus-specific CD4 + and CD8 + T cells dominate the memory compartments of exposed subjects. J Exp Med. 2005;202(5):673-85. 16147978 10.1084/jem.20050882 2212883
22. Mattes FM Vargas A Kopycinski J: Functional impairment of cytomegalovirus specific CD8 T cells predicts high-level replication after renal transplantation. Am J Transplant. 2008;8(5):990-9. 18325078 10.1111/j.1600-6143.2008.02191.x
23. Nebbia G Mattes FM Smith C: Polyfunctional cytomegalovirus-specific CD4+ and pp65 CD8+ T cells protect against high-level replication after liver transplantation. Am J Transplant. 2008;8(12):2590-9. 18853954 10.1111/j.1600-6143.2008.02425.x
24. Crough T Fazou C Weiss J: Symptomatic and asymptomatic viral recrudescence in solid-organ transplant recipients and its relationship with the antigen-specific CD8 + T-cell response. J Virol. 2007;81(20):11538-42. 17686874 10.1128/JVI.00581-07 2045544
25. Manuel O Husain S Kumar D: Assessment of cytomegalovirus-specific cell-mediated immunity for the prediction of cytomegalovirus disease in high-risk solid-organ transplant recipients: a multicenter cohort study. Clin Infect Dis. 2013;56(6):817-24. 23196955 10.1093/cid/cis993
26. Saldan A Forner G Mengoli C: Strong Cell-Mediated Immune Response to Human Cytomegalovirus Is Associated With Increased Risk of Fetal Infection in Primarily Infected Pregnant Women. Clin Infect Dis. 2015;61(8):1228-34. 26175520 10.1093/cid/civ561
27. Eldar-Yedidia Y Bar-Meir M Hillel M: Low Interferon Relative-Response to Cytomegalovirus Is Associated with Low Likelihood of Intrauterine Transmission of the Virus. PLoS One. 2016;11(2):e0147883. 26881863 10.1371/journal.pone.0147883 4755570
28. Forner G Saldan A Mengoli C: Cytomegalovirus (CMV) Enzyme-Linked Immunosorbent Spot Assay but Not CMV QuantiFERON Assay Is a Novel Biomarker To Determine Risk of Congenital CMV Infection in Pregnant Women. J Clin Microbiol. 2016;54(8):2149-54. 27280418 10.1128/JCM.00561-16 4963489
29. Bialas KM Tanaka T Tran D: Maternal CD4 + T cells protect against severe congenital cytomegalovirus disease in a novel nonhuman primate model of placental cytomegalovirus transmission. Proc Natl Acad Sci U S A. 2015;112(44):13645-50. 26483473 10.1073/pnas.1511526112 4640765
30. Forsgren M: Prevention of congenital and perinatal infections. Euro Surveill. 2009;14(9):2-4. 19317975
31. Rahav G: Congenital cytomegalovirus infection--a question of screening. Isr Med Assoc J. 2007;9(5):392-4. 17591383
32. Yinon Y Farine D Yudin MH: Screening, diagnosis, and management of cytomegalovirus infection in pregnancy. Obstet Gynecol Surv. 2010;65(11):736-43. 21375790 10.1097/OGX.0b013e31821102b4
33. Liesnard C Donner C Brancart F: Prenatal diagnosis of congenital cytomegalovirus infection: prospective study of 237 pregnancies at risk. Obstet Gynecol. 2000;95(6 Pt 1):881-8. 10831985 10.1016/S0029-7844(99)00657-2
34. Bodeus M Hubinont C Bernard P: Prenatal diagnosis of human cytomegalovirus by culture and polymerase chain reaction: 98 pregnancies leading to congenital infection. Prenat Diagn. 1999;19(4):314-7. 10327134 10.1002/(SICI)1097-0223(199904)19:4<314::AID-PD542>3.0.CO;2-H
35. Donner C Liesnard C Brancart F: Accuracy of amniotic fluid testing before 21 weeks' gestation in prenatal diagnosis of congenital cytomegalovirus infection. Prenat Diagn. 1994;14(11):1055-9. 7877953 10.1002/pd.1970141108
36. Enders G Bäder U Lindemann L: Prenatal diagnosis of congenital cytomegalovirus infection in 189 pregnancies with known outcome. Prenat Diagn. 2001;21(5):362-77. 11360277 10.1002/pd.59
37. Gouarin S Gault E Vabret A: Real-time PCR quantification of human cytomegalovirus DNA in amniotic fluid samples from mothers with primary infection. J Clin Microbiol. 2002;40(5):1767-72. 11980958 10.1128/JCM.40.5.1767-1772.2002 130652
38. Lipitz S Yagel S Shalev E: Prenatal diagnosis of fetal primary cytomegalovirus infection. Obstet Gynecol. 1997;89(5 Pt 1):763-7. 9166317 10.1016/S0029-7844(97)00084-7
39. Mulongo KN Lamy ME van Lierde M: Requirements for diagnosis of prenatal cytomegalovirus infection by amniotic fluid culture. Clin Diagn Virol. 1995;4(3):231-8. 15566843 10.1016/0928-0197(95)00003-Q
40. Revello MG Gerna G: Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant. Clin Microbiol Rev. 2002;15(4):680-715. 12364375 10.1128/CMR.15.4.680-715.2002 126858
41. Lazzarotto T Guerra B Gabrielli L: Update on the prevention, diagnosis and management of cytomegalovirus infection during pregnancy. Clin Microbiol Infect. 2011;17(9):1285-93. 21631642 10.1111/j.1469-0691.2011.03564.x
42. Bilavsky E Pardo J Attias J: Clinical Implications for Children Born With Congenital Cytomegalovirus Infection Following a Negative Amniocentesis. Clin Infect Dis. 2016;63(1):33-8. 27114380 10.1093/cid/ciw237 F1000 Recommendation
43. Tabata T Petitt M Fang-Hoover J: Cytomegalovirus impairs cytotrophoblast-induced lymphangiogenesis and vascular remodeling in an in vivo human placentation model. Am J Pathol. 2012;181(5):1540-59. 22959908 10.1016/j.ajpath.2012.08.003 3483806 F1000 Recommendation
44. Tabata T Petitt M Zydek M: Human cytomegalovirus infection interferes with the maintenance and differentiation of trophoblast progenitor cells of the human placenta. J Virol. 2015;89(9):5134-47. 25741001 10.1128/JVI.03674-14 4403461 F1000 Recommendation
45. Gabrielli L Bonasoni MP Santini D: Congenital cytomegalovirus infection: patterns of fetal brain damage. Clin Microbiol Infect. 2012;18(10):E419-27. 22882294 10.1111/j.1469-0691.2012.03983.x
46. Tabata T Petitt M Fang-Hoover J: Persistent Cytomegalovirus Infection in Amniotic Membranes of the Human Placenta. Am J Pathol. 2016;186(11):2970-86. 27638253 10.1016/j.ajpath.2016.07.016 5222962 F1000 Recommendation
47. van Zuylen WJ Ford CE Wong DD: Human Cytomegalovirus Modulates Expression of Noncanonical Wnt Receptor ROR2 To Alter Trophoblast Migration. J Virol. 2015;90(2):1108-15. 26559837 10.1128/JVI.02588-15 4702663 F1000 Recommendation
48. Hamilton ST Scott G Naing Z: Human cytomegalovirus-induces cytokine changes in the placenta with implications for adverse pregnancy outcomes. PLoS One. 2012;7(12):e52899. 23300810 10.1371/journal.pone.0052899 3534118 F1000 Recommendation
49. Weisblum Y Panet A Zakay-Rones Z: Human cytomegalovirus induces a distinct innate immune response in the maternal-fetal interface. Virology. 2015;485:289-96. 26318261 10.1016/j.virol.2015.06.023 F1000 Recommendation
50. Cannon MJ Griffiths PD Aston V: Universal newborn screening for congenital CMV infection: what is the evidence of potential benefit? Rev Med Virol. 2014;24(5):291-307. 24760655 10.1002/rmv.1790 4494732 F1000 Recommendation
51. Boppana SB Ross SA Novak Z: Dried blood spot real-time polymerase chain reaction assays to screen newborns for congenital cytomegalovirus infection. JAMA. 2010;303(14):1375-82. 20388893 10.1001/jama.2010.423 2997517 F1000 Recommendation
52. de Vries JJ Claas EC Kroes AC: Evaluation of DNA extraction methods for dried blood spots in the diagnosis of congenital cytomegalovirus infection. J Clin Virol. 2009;46(Suppl 4):S37-42. 19781984 10.1016/j.jcv.2009.09.001
53. Vauloup-Fellous C Ducroux A Couloigner V: Evaluation of cytomegalovirus (CMV) DNA quantification in dried blood spots: retrospective study of CMV congenital infection. J Clin Microbiol. 2007;45(11):3804-6. 17898161 10.1128/JCM.01654-07 2168533
54. Atkinson C Emery VC Griffiths PD: Development of a novel single tube nested PCR for enhanced detection of cytomegalovirus DNA from dried blood spots. J Virol Methods. 2014;196:40-4. 24184085 10.1016/j.jviromet.2013.10.029
55. Boppana SB Ross SA Shimamura M: Saliva polymerase-chain-reaction assay for cytomegalovirus screening in newborns. N Engl J Med. 2011;364(22):2111-8. 21631323 10.1056/NEJMoa1006561 3153859 F1000 Recommendation
56. Doyle M Atkins JT Rivera-Matos IR: Congenital cytomegalovirus infection in infants infected with human immunodeficiency virus type 1. Pediatr Infect Dis J. 1996;15(12):1102-6. 8970220 10.1097/00006454-199612000-00010
57. Kovacs A Schluchter M Easley K: Cytomegalovirus infection and HIV-1 disease progression in infants born to HIV-1-infected women. Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection Study Group. N Engl J Med. 1999;341(2):77-84. 10395631 10.1056/NEJM199907083410203 4280563
58. Slyker JA Lohman-Payne BL John-Stewart GC: Acute cytomegalovirus infection in Kenyan HIV-infected infants. AIDS. 2009;23(16):2173-81. 19617812 10.1097/QAD.0b013e32833016e8 2761509
59. Roxby AC Atkinson C Asbjörnsdóttir K: Maternal valacyclovir and infant cytomegalovirus acquisition: a randomized controlled trial among HIV-infected women. PLoS One. 2014;9(2):e87855. 24504006 10.1371/journal.pone.0087855 3913686
60. Leruez-Ville M Ghout I Bussières L: In utero treatment of congenital cytomegalovirus infection with valacyclovir in a multicenter, open-label, phase II study. Am J Obstet Gynecol. 2016;215(4):462.e1-462.e10. 27083761 10.1016/j.ajog.2016.04.003 F1000 Recommendation
61. Slyker JA Richardson B Chung MH: Maternal Highly Active Antiretroviral Therapy Reduces Vertical Cytomegalovirus Transmission But Does Not Reduce Breast Milk Cytomegalovirus Levels. AIDS Res Hum Retroviruses. 2016. 27796131 10.1089/AID.2016.0121
62. Kimberlin DW Jester PM Sánchez PJ: Valganciclovir for symptomatic congenital cytomegalovirus disease. N Engl J Med. 2015;372(10):933-43. 25738669 10.1056/NEJMoa1404599 4401811 F1000 Recommendation
63. Kimberlin DW Lin CY Sánchez PJ: Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial. J Pediatr. 2003;143(1):16-25. 12915819 10.1016/S0022-3476(03)00192-6
64. Rawlinson WD Boppana S Fowler KB: Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapy. Lancet Infect Dis. 2016. (in press).
65. Griffiths PD McLean A Emery VC: Encouraging prospects for immunisation against primary cytomegalovirus infection. Vaccine. 2001;19(11-12):1356-62. 11163656 10.1016/S0264-410X(00)00377-7
66. Griffiths PD: Burden of disease associated with human cytomegalovirus and prospects for elimination by universal immunisation. Lancet Infect Dis. 2012;12(10):790-8. 23017365 10.1016/S1473-3099(12)70197-4 F1000 Recommendation
67. Pass RF Zhang C Evans A: Vaccine prevention of maternal cytomegalovirus infection. N Engl J Med. 2009;360(12):1191-9. 19297572 10.1056/NEJMoa0804749 2753425 F1000 Recommendation
68. Schleiss MR Berka U Watson E: Additive Protection against Congenital Cytomegalovirus Conferred by Combined Glycoprotein B/pp65 Vaccination Using a Lymphocytic Choriomeningitis Virus Vector. Clin Vaccine Immunol. 2017;24(1): pii: e00300-16. 27795301 10.1128/CVI.00300-16 5216435 F1000 Recommendation
69. Revello MG Lazzarotto T Guerra B: A randomized trial of hyperimmune globulin to prevent congenital cytomegalovirus. N Engl J Med. 2014;370(14):1316-26. 24693891 10.1056/NEJMoa1310214
70. Nigro G Adler SP La Torre R: Passive immunization during pregnancy for congenital cytomegalovirus infection. N Engl J Med. 2005;353(13):1350-62. 16192480 10.1056/NEJMoa043337
71. Hamilton ST van Zuylen W Shand A: Prevention of congenital cytomegalovirus complications by maternal and neonatal treatments: a systematic review. Rev Med Virol. 2014;24(6):420-33. 25316174 10.1002/rmv.1814 F1000 Recommendation